SILVERBACK THERAPEUTICS INC (SBTX)

US82835W1080 - Common Stock

5.87  +0.06 (+1.03%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
84.92M89.58M32.92M24.07M18.32M
Research and Development
52.08M61.50M24.58M21.51M14.80M
Selling, General, and Administrative Expenses
32.85M28.08M8.34M2.56M3.52M
Operating Income
-84.92M-89.58M-32.92M-24.07M-18.32M
Interest Income/Expense
1.56M106.00K-30.00K100.00K40.00K
Other Income/Expense
N/AN/AN/A0.00700.00K
Income Before Taxes
-85.38M-89.48M-32.95M-23.97M-17.58M
Net Income
-85.38M-89.48M-32.95M-23.97M-17.58M
EBITDA
-84.20M-88.80M-32.28M-23.53M-17.84M
 
Per Share Data
EPS Diluted Total Ops
-2.43-2.56-1.00-0.72-0.53
Non GAAP EPS
N/A-2.56N/AN/AN/A
 
Statistics

All data in USD

Charts